Vaccine -- The Canadian Press

By The Canadian Press

Health Canada approves Pfizer-BioNTech COVID-19 vaccine for children 5 to 11

Nov 19, 2021 | 7:51 AM

OTTAWA, ONT. – Health Canada has approved the first COVID-19 vaccine for children aged five to 11 in Canada.

Pfizer and its partner BioNTech submitted a request for approval of a child-sized dose of its mRNA vaccine for COVID-19 on Oct. 18.

READ MORE: Alberta expecting arrival of COVID vaccines for children aged 5-11 next week

The companies say the results of their trials in children show comparable safety and efficacy results to those recorded in a previous Pfizer-BioNTech study in adults aged 16 to 25.

Health Canada said it would only approve the vaccine for children if its analysis showed the benefits outweigh the potential risks.

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025

What's Happening in Lethbridge this week: February 10-16, 2025

Feb 10, 2025

Pfizer-BioNTech has changed the formulation of the pediatric vaccine slightly, so new vaccines must be delivered to Canada before children can receive a shot.

Canada is expecting an accelerated delivery of 2.9 million child-sized doses, enough for a first dose for every child in the five to 11 age group.

(More to come)

For local news delivered daily to your email inbox, subscribe for free to the Lethbridge News Now newsletter here. You can also download the Lethbridge News Now mobile app in the Google Play and the Apple App Stores.